OTCMKTS:CBIS - Cannabis Science Stock Price, News & Analysis

0.00 (0.00 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
Now: $0.0233
50-Day Range
MA: $0.03
52-Week Range
Now: $0.0233
Volume2.97 million shs
Average Volume4.84 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Cannabis Science, Inc, together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Current SymbolOTCMKTS:CBIS



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive CBIS News and Ratings via Email

Sign-up to receive the latest news and ratings for CBIS and its competitors with MarketBeat's FREE daily newsletter.

Cannabis Science (OTCMKTS:CBIS) Frequently Asked Questions

What is Cannabis Science's stock symbol?

Cannabis Science trades on the OTCMKTS under the ticker symbol "CBIS."

How were Cannabis Science's earnings last quarter?

Cannabis Science Inc (OTCMKTS:CBIS) posted its quarterly earnings results on Tuesday, July, 28th. The company reported $0.00 earnings per share for the quarter. View Cannabis Science's Earnings History.

Has Cannabis Science been receiving favorable news coverage?

News headlines about CBIS stock have trended positive on Saturday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cannabis Science earned a news sentiment score of 2.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next few days. View News Stories for Cannabis Science.

Who are some of Cannabis Science's key competitors?

What other stocks do shareholders of Cannabis Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Science investors own include Medical Marijuana (MJNA), Canopy Growth (CGC), Terra Tech (TRTC), Cronos Group (CRON), 22nd Century Group (XXII), Aurora Cannabis (ACBFF), Hemp (HEMP), Energous (WATT), Aurora Cannabis (ACB) and United Cannabis (CNAB).

Who are Cannabis Science's key executives?

Cannabis Science's management team includes the folowing people:
  • Mr. Raymond C. Dabney, Co-Founder, Chairman, CEO & Pres (Age 54)
  • Mr. Benjamin C. K. Tam, CFO, Sec. & Director (Age 67)
  • Mr. Robert James Kane, COO & Director (Age 43)
  • Mr. Mario Lap, Pres of European Operations & Director (Age 67)
  • Mr. Bret Bogue, Director of Horticulture and Head of R&D

How do I buy shares of Cannabis Science?

Shares of CBIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cannabis Science's stock price today?

One share of CBIS stock can currently be purchased for approximately $0.0233.

What is Cannabis Science's official website?

The official website for Cannabis Science is http://www.cannabisscience.com/.

How can I contact Cannabis Science?

Cannabis Science's mailing address is 19800 Macarthur Blvd Ste 300, IRVINE, CA 92612-2479, United States. The company can be reached via phone at +1-888-8890888.

MarketBeat Community Rating for Cannabis Science (OTCMKTS CBIS)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  168 (Vote Underperform)
Total Votes:  382
MarketBeat's community ratings are surveys of what our community members think about Cannabis Science and other stocks. Vote "Outperform" if you believe CBIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBIS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Featured Article: Options Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel